Skip to main content
SpringerLink
Log in

Therapie mit krankheitsmodifizierenden Medikamenten bei Multipler Sklerose

Neue Praxisleitlinien aus den USA

  • journal club
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Rae-Grant A, Day GS, Marrie RA et al. Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2018; 90: 777–88

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. St. Josef-Hospital, Klinikum der Ruhr-Universität Bochum, Gudrunstr. 56, 44791, Bochum, Deutschland

    Simon Faissner

Authors
  1. Simon Faissner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Simon Faissner.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Faissner, S. Neue Praxisleitlinien aus den USA. InFo Neurologie 20, 16–17 (2018). https://doi.org/10.1007/s15005-018-2742-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-018-2742-3

Search

Navigation